notamedik

Drugs

101 drugs, with the doses from our notes. Each one links to the note it comes from and names its source.

Acebutolol

β-blocker

Hypertension

Start
200 mg BD
Maximum daily
1.2 g in divided doses

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Adrenaline (epinephrine)

Vasopressor

Cardiac arrest in pregnancy

Dose
adrenaline (epinephrine) IV/IO every 3-5 minutes

From Maternal Collapse › D: Defibrillation · OLSS lectures, HOSHAS Temerloh 2026

Alirocumab

PCSK9 inhibitor

Dyslipidaemia

Dose
75-150 mg SC every 2 weeks, or 300 mg SC monthly

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Amiloride/hydrochlorothiazide 5 mg/50 mg

Diuretic

Hypertension

Start
1 tablet OD
Maximum daily
1 tablet OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Amlodipine

Calcium channel blocker (dihydropyridine)

Hypertension

Start
5 mg OD
Maximum daily
10 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Ampicillin

Penicillin

Prophylaxis after uterine inversion

Option 1
ampicillin 2 g IV + metronidazole 500 mg IV
Option 2
cefazolin 1 g IV + metronidazole 500 mg IV

From Uterine Inversion › After replacement · OLSS lectures, HOSHAS Temerloh 2026

Atenolol

β-blocker

Hypertension

Start
50 mg OD
Maximum daily
100 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Atorvastatin

Statin

Dyslipidaemia

High intensity
Atorvastatin 40-80 mg
Moderate intensity
Atorvastatin 10-20 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Dyslipidaemia in CKD stage 3a-5

mg/day
20

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Basal insulin

Insulin

Type 2 diabetes: starting insulin

Start
Basal insulin 10 U OD or 0.1-0.2 U/kg/day
Titrate
+2 U every 3 days
Hypoglycaemia
Hypoglycaemia → reduce the dose by 10-20%.

From Type 2 DM › Insulin: start and titrate · CPG Management of T2DM 2020, Figure 3-2

Betaxolol

β-blocker

Hypertension

Start
10 mg OD
Maximum daily
20 mg/day

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Bezafibrate

Fibrate

Dyslipidaemia

Dose
200 mg daily, increasing gradually over 5-7 days to max 200 mg TDS (regular), or 400 mg daily (sustained release)

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Bisoprolol

β-blocker

Hypertension

Start
5 mg OD (CrCl <40: 2.5 mg/day)
Maximum daily
20 mg/day

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Calcium gluconate

Electrolyte

Antidote for magnesium toxicity

Dose
1 g calcium gluconate (10 mL of 10% solution) by slow IV bolus over 3 minutes.

From Eclampsia › Magnesium toxicity · OLSS lectures, HOSHAS Temerloh 2026

Candesartan

Angiotensin receptor blocker

Hypertension

Start
8 mg OD
Maximum daily
32 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Captopril

ACE inhibitor

Hypertension

Start
25 mg BD
Maximum daily
50 mg TDS

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Carbetocin

Uterotonic (long-acting oxytocin analogue)

PPH

Dose
100 µg IV bolus over 1 minute
Repeat
Single dose: do not repeat
Caution
never before delivery of the fetus

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Carboprost

Uterotonic (prostaglandin F2α analogue)

PPH

Dose
250 µg IM, repeated every 15-90 min as required, maximum 2 mg (8 doses)
Contraindicated
Contraindicated in cardiac, pulmonary, renal or hepatic disease

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Resuscitative hysterotomy, third stage

Dose
intramyometrial carboprost 250 mcg

From Maternal Collapse › Resuscitative hysterotomy (perimortem caesarean) · OLSS lectures, HOSHAS Temerloh 2026

Carvedilol

α, β-blocker

Hypertension

Start
12.5 mg OD
Maximum daily
50 mg OD, or in divided doses (HF/angina dosing differs)

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Cefazolin

Cephalosporin

Prophylaxis after uterine inversion

Option 1
ampicillin 2 g IV + metronidazole 500 mg IV
Option 2
cefazolin 1 g IV + metronidazole 500 mg IV

From Uterine Inversion › After replacement · OLSS lectures, HOSHAS Temerloh 2026

Clonidine

Centrally acting

Hypertension

Start
50 mcg TDS
Maximum daily
2400 mcg daily
Caution
discouraged; never stop suddenly

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Diltiazem

Calcium channel blocker (non-dihydropyridine)

Hypertension

Start
90 mg BD
Maximum daily
180 mg BD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Diltiazem SR

Calcium channel blocker (non-dihydropyridine)

Hypertension

Start
100 mg OD
Maximum daily
200 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Doxazosin

Peripheral α-blocker

Hypertension

Start
1 mg OD
Maximum daily
16 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Dulaglutide

GLP1 receptor agonist

Type 2 diabetes

Start
No titration
Usual dose
0.75 mg weekly (mono), 1.5 mg weekly (add-on)
Renal
eGFR <15 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Enalapril

ACE inhibitor

Hypertension

Start
10 mg OD
Maximum daily
40 mg daily

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Ergometrine

Uterotonic (ergot alkaloid)

Uterus not contracting after inversion is corrected

Dose
ergometrine 0.2 mg or prostaglandins

From Uterine Inversion › After replacement · OLSS lectures, HOSHAS Temerloh 2026

Pre-eclampsia

Third stage
Avoid ergometrine in the third stage of labour.

From Eclampsia › Postpartum care · OLSS lectures, HOSHAS Temerloh 2026

Evolocumab

PCSK9 inhibitor

Dyslipidaemia

Dose
140 mg SC every 2 weeks, or 420 mg SC monthly

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Exenatide

GLP1 receptor agonist

Type 2 diabetes

Start
5 µg BD for ≥1 month
Usual dose
5-10 µg BD, within 60 min before main meals
Renal
eGFR <30 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Exenatide ER

GLP1 receptor agonist

Type 2 diabetes

Start
No titration
Usual dose
2 mg weekly
Renal
eGFR <30 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Ezetimibe

Cholesterol absorption inhibitor

Dyslipidaemia

Dose
10 mg daily. No adjustment for mild hepatic impairment or mild-moderate kidney disease; not recommended in moderate-severe hepatic impairment

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Felodipine

Calcium channel blocker (dihydropyridine)

Hypertension

Start
5 mg OD
Maximum daily
10 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Fenofibrate

Fibrate

Dyslipidaemia

Dose
100 mg TDS, 145 mg daily (nanoparticles), or 160 mg daily (micronised)

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Fluvastatin

Statin

Dyslipidaemia

Moderate intensity
Fluvastatin 40 mg BD
Low intensity
Fluvastatin 20-40 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Dyslipidaemia in CKD stage 3a-5

mg/day
80

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Gemfibrozil

Fibrate

Dyslipidaemia

Dose
600-1200 mg daily in divided doses, 30 minutes before meals (max 1.5 g/day). Not with statins

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Gentamicin

Aminoglycoside

Maternal sepsis

Dose
Gentamicin, single dose 3-5 mg/kg
Notes
Needs level monitoring if given regularly. Nephrotoxic and ototoxic

From Maternal Sepsis › Antibiotic choices · OLSS lectures, HOSHAS Temerloh 2026

Hydrochlorothiazide

Diuretic

Hypertension

Start
12.5 mg OD
Maximum daily
25 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Hydrocortisone

Corticosteroid

Septic shock not responding to norepinephrine

Dose
hydrocortisone 200 mg/day as a continuous infusion

From Maternal Sepsis › Supportive care · OLSS lectures, HOSHAS Temerloh 2026

Imidapril

ACE inhibitor

Hypertension

Start
5 mg OD
Maximum daily
20 mg daily

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Inclisiran

siRNA PCSK9 inhibitor

Dyslipidaemia

Dose
284 mg SC once, again at 3 months, then every 6 months

From Dyslipidaemia › Non-statins · CPG Management of Dyslipidaemia 2023, Sections 7.2.2-7.2.5

Indapamide SR

Diuretic

Hypertension

Start
1.5 mg OD
Maximum daily
1.5 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Irbesartan

Angiotensin receptor blocker

Hypertension

Start
150 mg OD
Maximum daily
300 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Isradipine

Calcium channel blocker (dihydropyridine)

Hypertension

Start
2.5 mg BD
Maximum daily
10 mg BD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Labetalol

α, β-blocker

Hypertension

Start
100 mg BD (elderly: 50 mg BD)
Maximum daily
2.4 g/day in 2-4 divided doses

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Severe hypertension in pregnancy (IV)

Initial
20 mg
Repeat doses
20, 40, 40 mg
Notes
Repeat every 10 minutes, up to a maximum of 300 mg. Avoid in bradycardia, heart block or severe asthma

From Eclampsia › Antihypertensives for severe hypertension · OLSS lectures, HOSHAS Temerloh 2026

Lercanidipine

Calcium channel blocker (dihydropyridine)

Hypertension

Start
10 mg OD
Maximum daily
20 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Liraglutide

GLP1 receptor agonist

Type 2 diabetes

Start
0.6 mg OD for ≥1 week
Usual dose
1.2-1.8 mg OD
Renal
eGFR <15 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Lisinopril

ACE inhibitor

Hypertension

Start
10 mg OD
Maximum daily
80 mg daily

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Lixisenatide

GLP1 receptor agonist

Type 2 diabetes

Start
10 µg OD for 14 days
Usual dose
20 µg OD
Renal
eGFR <30 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Losartan

Angiotensin receptor blocker

Hypertension

Start
50 mg OD
Maximum daily
100 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Lovastatin

Statin

Dyslipidaemia

Moderate intensity
Lovastatin 40 mg
Low intensity
Lovastatin 20 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Dyslipidaemia in CKD stage 3a-5

mg/day
Not studied

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Magnesium sulphate

Anticonvulsant

Eclampsia prophylaxis and treatment

Loading (IV)
4 g (8 mL) MgSO₄ with 12 mL normal saline over 15 minutes
Loading (IM)
10 g, given as 5 g (10 mL) MgSO₄ into each buttock (add 1 mL of 2% lignocaine)
Maintenance (IV)
24.7 g (10 ampoules) MgSO₄ in 500 mL normal saline at 1 g/hour (21 mL/h)
Maintenance (IM)
5 g (10 mL) MgSO₄ deep IM into alternate buttocks every 4 hours
Recurrent seizure
2 g (4 mL) + 8 mL normal saline over 15 minutes
Duration
continue for 24 hours after delivery or after starting it, whichever is later

From Eclampsia › Magnesium sulphate regime · OLSS lectures, HOSHAS Temerloh 2026

α-methyldopa

Centrally acting

Hypertension

Start
250 mg BD-TDS
Maximum daily
3000 mg daily

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

After pre-eclampsia / eclampsia

Postpartum
avoid continuing or starting methyldopa

From Eclampsia › Postpartum care · OLSS lectures, HOSHAS Temerloh 2026

Metoprolol

β-blocker

Hypertension

Start
50 mg BD
Maximum daily
200 mg BD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Metronidazole

Nitroimidazole

Prophylaxis after uterine inversion

Option 1
ampicillin 2 g IV + metronidazole 500 mg IV
Option 2
cefazolin 1 g IV + metronidazole 500 mg IV

From Uterine Inversion › After replacement · OLSS lectures, HOSHAS Temerloh 2026

Misoprostol

Uterotonic (prostaglandin E1 analogue)

PPH

Dose
800-1,000 µg (4-5 tablets) per rectum
Notes
Off-label. Use when oxytocin and ergometrine fail or aren't available

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Moxonidine

Centrally acting

Hypertension

Start
200 mcg OD; avoid if GFR <30
Maximum daily
600 mcg in 2 divided doses; 400 mcg daily if GFR 30-60

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Nebivolol

β-blocker

Hypertension

Start
5 mg OD
Maximum daily
40 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Nifedipine

Calcium channel blocker (dihydropyridine)

Hypertension

Start
5 mg TDS
Maximum daily
20 mg TDS

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Severe hypertension in pregnancy (oral)

Initial
10 mg
Repeat doses
10-20 mg
Notes
Maximum of 3 doses. She should not bite the capsule. Causes headache and tachycardia

From Eclampsia › Antihypertensives for severe hypertension · OLSS lectures, HOSHAS Temerloh 2026

Olmesartan

Angiotensin receptor blocker

Hypertension

Start
20 mg OD
Maximum daily
40 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Oxytocin

Uterotonic

PPH

Bolus
5 IU IV slowly over 1-2 min
Repeat
after 5 min repeat as required to a maximum total of 10 IU
Infusion
Infusion 5-10 IU/hour (125-250 mL/h): 40 IU in 500 mL-1 L of crystalloid / 0.9% NaCl
Cautions
Overdose or prolonged use causes water intoxication; IV push can cause hypotension

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Resuscitative hysterotomy, third stage

Dose
IM oxytocin 10 IU

From Maternal Collapse › Resuscitative hysterotomy (perimortem caesarean) · OLSS lectures, HOSHAS Temerloh 2026

After replacing an inverted uterus

Infusion
oxytocin 20 U in 500 mL IV fluid at 10 drops/min

From Uterine Inversion › After replacement · OLSS lectures, HOSHAS Temerloh 2026

Perindopril

ACE inhibitor

Hypertension

Start
4 mg (erbumine) or 5 mg (arginine) OD
Maximum daily
8 mg (erbumine) or 10 mg (arginine) OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Pitavastatin

Statin

Dyslipidaemia

Moderate intensity
Pitavastatin 2-4 mg
Low intensity
Pitavastatin 1 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Prandial insulin

Insulin

Type 2 diabetes: basal plus

Start
Add prandial insulin 4 U/meal or 10% of the basal dose
Titrate
+1-2 U or 10-15% every 3 days
Hypoglycaemia
Hypoglycaemia → reduce prandial insulin by 10-20%.

From Type 2 DM › Insulin: start and titrate · CPG Management of T2DM 2020, Figure 3-2

Pravastatin

Statin

Dyslipidaemia

Moderate intensity
Pravastatin 40-80 mg
Low intensity
Pravastatin 10-20 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Dyslipidaemia in CKD stage 3a-5

mg/day
40

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Prazosin

Peripheral α-blocker

Hypertension

Start
0.5 mg BD-TDS
Maximum daily
20 mg in divided doses

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Propranolol

β-blocker

Hypertension

Start
40 mg BD
Maximum daily
320 mg BD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Ramipril

ACE inhibitor

Hypertension

Start
2.5 mg OD
Maximum daily
10 mg daily

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Recombinant factor VIIa

Haemostatic

Life-threatening PPH

Dose
90 µg/kg IV over 3-5 min
Repeat
2nd dose after 20-30 min, maximum 2 doses
Before use
Optimise platelets, fibrinogen, pH and temperature first

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Rosuvastatin

Statin

Dyslipidaemia

High intensity
Rosuvastatin 20-40 mg
Moderate intensity
Rosuvastatin 5-10 mg

From Dyslipidaemia › Statins by intensity · CPG Management of Dyslipidaemia 2023, Table 12 (daily doses)

Dyslipidaemia in CKD stage 3a-5

mg/day
10

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Salbutamol

β2-agonist (tocolytic)

Tocolysis to replace an inverted uterus

Dose
IV salbutamol 75-150 mcg bolus

From Uterine Inversion › Tocolytics · OLSS lectures, HOSHAS Temerloh 2026

Semaglutide

GLP1 receptor agonist

Type 2 diabetes

Start
0.25 mg weekly for 4 weeks
Usual dose
0.5-1.0 mg weekly (increase after 4 weeks if needed)
Renal
eGFR <15 avoid

From Type 2 DM › GLP1-RA · CPG Management of T2DM 2020, Appendix 7

Simvastatin/ezetimibe

Statin + cholesterol absorption inhibitor

Dyslipidaemia in CKD stage 3a-5

mg/day
20/10

From Dyslipidaemia › Statins in CKD · CPG Management of Dyslipidaemia 2023, Table 15 (from KDIGO 2013)

Syntometrine

Uterotonic (oxytocin 5 IU + ergometrine 0.5 mg)

PPH

Dose
1 ampoule (1 mL) IM
Repeat
Repeat 1 mL no sooner than 2 hours if necessary; no more than 3 mL in 24 hours
Avoid in
Avoid in retained placenta, severe hypertension, hepatic, renal or cardiac disease, sepsis

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Telmisartan

Angiotensin receptor blocker

Hypertension

Start
40 mg OD
Maximum daily
80 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Terazosin

Peripheral α-blocker

Hypertension

Start
1 mg ON
Maximum daily
20 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Terbutaline

β2-agonist (tocolytic)

Tocolysis to replace an inverted uterus

Dose
SC terbutaline 0.25 mg

From Uterine Inversion › Tocolytics · OLSS lectures, HOSHAS Temerloh 2026

Tranexamic acid

Antifibrinolytic

PPH

Loading
Loading 1 g IV over 10 min (in 100 mL 0.9% NaCl); a further 1 g 30 min later if required
Maintenance
Maintenance: 1 g in 100 mL 0.9% NaCl over 8 hours
Avoid
Avoid in active thromboembolism

From PPH › Uterotonics and other drugs · OLSS PPH lecture (OGSM Handbook of Obstetric Emergencies drug table)

Valsartan

Angiotensin receptor blocker

Hypertension

Start
80 mg OD
Maximum daily
320 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Verapamil

Calcium channel blocker (non-dihydropyridine)

Hypertension

Start
80 mg TDS
Maximum daily
160 mg TDS

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C

Verapamil SR

Calcium channel blocker (non-dihydropyridine)

Hypertension

Start
120 mg OD
Maximum daily
480 mg OD

From Hypertension › Usual doses · CPG Management of Hypertension 2018, Tables 9.1-A to 9.5-C